Y. Gazitt et al., Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilization, J HEMATOTH, 8(2), 1999, pp. 173-183
Citations number
24
Categorie Soggetti
Hematology,"Medical Research Diagnosis & Treatment
PBSC are the preferred source of stem cells for autologous transplantation.
However, regardless of the mobilization procedure used, 10%-20% of patient
s fail to collect an adequate number to ensure prompt engraftment. There is
as yet no standard mobilization procedure for patients who fail a first mo
bilization attempt. Here, we describe a highly efficient strategy to obtain
an adequate number of stem cells for patients who failed a first mobilizat
ion attempt. Seventy-four patients with various hematologic malignancies un
derwent initial mobilization with various regimens including hematopoietic
growth factors with or without chemotherapy. In 72% of patients, greater th
an or equal to 2 x 10(6) CD34(+) stem cells/kg were collected in the initia
l mobilization attempt, and patients engrafted in a median of 10 days for n
eutrophils and 12 days for platelets. Eighteen patients failed to mobilize
adequate numbers of stem cells, defined as the inability to collect 0.2 x 1
0(6) CD34(+) stem cells/kg/day in the first 2-3 days. These patients had th
eir apheresis halted. Patients were immediately given G-CSF (32 mu g/kg/day
) for 4 days as a second attempt at mobilization. Eighty-eight percent of t
hese patients achieved the target of greater than or equal to 2 x 10(6) CD3
4(+) cells/kg, with a median duration of apheresis of 5 days (including the
first and second mobilizations). The mean CD34(+) cells/kg/day increased a
fter administration of high-dose G-CSF from 0.16 after the first mobilizati
on attempt to 0.61 (p = 0.0002) after the second mobilization. All patients
engrafted in a median of 11 and 13 days for neutrophils and platelets, res
pectively. We conclude that patients whose apheresis yield is <0.4 x 10(6)
CD34(+) cells/kg after the first two apheresis collections can be successfu
lly mobilized if high-dose G-CSF is administered immediately and continued
until achieving greater than or equal to 2 x 10(6) CD34(+) stem cells/kg.